About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Four Dimensions in Schizophrenia

NCT00782899·65 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Provision of written inform consent
Diagnosed of Schizophrenia of Schizoaffective Disorder based on DSM-IV-TR
With an acute episode or worsening of clinical status. Defined as change in clinical status that need a significant change in therapeutic plan.
Able to understand and comply with requirements of the study

You may not be if

Mental retardation
Unstable somatic disease, that is not receiving adequate treatment, based on investigator opinion.
To have been recruited in a clinical trial in the last 4 weeks
To have planned the inclusion in a clinical trial during the follow-up of this study

The record

StatusCompleted

PhaseNo phase

Taking part320

StartedOct 2008

UpdatedDec 10, 2010

Conditions

Where65

Research Site
Vitoria-Gasteiz, Alava, Spain
Research Site
Almansa, Albacete, Spain
Research Site
Alcoy, Alicante, Spain

Clareo Health | Four Dimensions in Schizophrenia